Diagnos, Inc. engages in the provision of healthcare technical services through the use of artificial intelligence (AI). The company is headquartered in Brossard, Quebec. The company went IPO on 2000-09-27. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. The company provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.
Follow-Up Questions
What is the price performance of DGNOF stock?
The current price of DGNOF is $0.19, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Diagnos Inc?
Diagnos Inc belongs to Health Care industry and the sector is Health Care
What is Diagnos Inc market cap?
Diagnos Inc's current market cap is $19.5M
Is Diagnos Inc a buy, sell, or hold?
According to wall street analysts, 3 analysts have made analyst ratings for Diagnos Inc, including 3 strong buy, 5 buy, 1 hold, 0 sell, and 3 strong sell
